Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07897968 |
| Title | GD2IL18CART Combined With Bevacizumab for Relapsed and Refractory GD2-positive Solid Tumors (GD2CART-BEV) |
| Acronym | GD2CART-BEV |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Universität Münster |
| Indications | |
| Therapies | |
| Age Groups: | adult | child |
| Covered Countries | DEU |